The measurement of SUVmax of the primary tumor is predictive of prognosis for patients with endometrial cancer

Gynecologic Oncology

Volumn 123, Issue 1, 2011, Pages 82-87

  Nakamura, Keiichiro ^a   Hongo, Atsushi ^a   Kodama, Junichi ^a   Hiramatsu, Yuji ^a  

^a OKAYAMA UNIVERSITY   (Japan)

Author keywords

Endometrial cancer; Maximum standardized uptake valve; Positron emission tomography computed tomography; Predictor for poor prognosis; Serum CA125

Indexed keywords

CA 125 ANTIGEN; CARBOPLATIN; FLUORODEOXYGLUCOSE F 18; PACLITAXEL; TUMOR MARKER;

ADULT; ARTICLE; CANCER INVASION; CANCER STAGING; CANCER SURVIVAL; CLINICAL FEATURE; COMPUTER ASSISTED EMISSION TOMOGRAPHY; CONTROLLED STUDY; CORRELATIONAL STUDY; DRUG TUMOR LEVEL; ENDOMETRIUM CANCER; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MAXIMUM STANDARDIZED UPTAKE VALUE; MULTIPLE CYCLE TREATMENT; OVERALL SURVIVAL; PREDICTION; PRIMARY TUMOR; PRIORITY JOURNAL; PROGNOSIS;

ADULT; AGED; AGED, 80 AND OVER; CA-125 ANTIGEN; CARCINOMA, ENDOMETRIOID; DISEASE-FREE SURVIVAL; ENDOMETRIAL NEOPLASMS; FEMALE; FLUORINE RADIOISOTOPES; FLUORODEOXYGLUCOSE F18; HUMANS; MEMBRANE PROTEINS; MIDDLE AGED; NEOPLASM STAGING; POSITRON-EMISSION TOMOGRAPHY; PREDICTIVE VALUE OF TESTS; PROGNOSIS; RADIOPHARMACEUTICALS; SURVIVAL RATE; TOMOGRAPHY, X-RAY COMPUTED;

EID: 80052572656     PISSN: 00908258     EISSN: 10956859     Source Type: Journal    
DOI: 10.1016/j.ygyno.2011.06.026     Document Type: Article

References (27)

1. A. Jemal, R. Siegel, J. Xu, and E. Ward Cancer statistics, 2010 CA Cancer J Clin 60 2010 277 300
2. Annual Report of Oncology Committee of Japan Society of Obstetrics and Gynecology, Tokyo, Japan 2011.
3. C.P. Morrow, B.N. Bundy, and R.J. Kurman Relationship between surgical-pathological risk factors and outcome in clinical stage I and II carcinoma of the endometrium: a Gynecologic Oncology Group study Gynecol Oncol 40 1991 55 65
4. J.G. Aalders, V. Abeler, and P. Kolstad Recurrent adenocarcinoma of the endometrium: a clinical and histopathological study of 379 patients Gynecol Oncol 17 1984 85 103 (Pubitemid 14176295)
5. M.L. Berman, S.C. Ballon, L.D. Lagasse, and W.G. Watring Prognosis and treatment of endometrial cancer Am J Obstet Gynecol 136 1980 679 688 (Pubitemid 10156234)
6. R.C. Boronow, C.P. Morrow, and W.T. Creasman Surgical staging in endometrial cancer: clinical-pathologic findings of a prospective study Obstet Gynecol 63 1984 825 832 (Pubitemid 14105231)
7. W.T. Creasman, C.P. Morrow, and B.N. Bundy Surgical pathologic spread patterns of endometrial cancer. A Gynecologic Oncology Group Study Cancer 60 1987 2035 2041 (Pubitemid 17145924)
8. D. Gal, F.O. Recio, D. Zamurovic, and M.L. Tancer Lymphvascular space involvement-a prognostic indicator in endometrial adenocarcinoma Gynecol Oncol 42 1991 142 145
9. D.M. Larson, G.P. Connor, and S.K. Broste Prognostic significance of gross myometrial invasion with endometrial cancer Obstet Gynecol 88 1996 394 398 (Pubitemid 26293285)
10. H.S. Kim, N.H. Park, and H.H. Chung Serum CA-125 level after 6 cycles of primary adjuvant chemotherapy is a useful prognostic factor for complete responders' survival in patients with advanced epithelial ovarian cancer Onkologie 31 2008 315 320 (Pubitemid 351839731)
11. P.G. Rose, R.M. Sommers, and F.R. Reale Serial serum CA 125 measurements for evaluation of recurrence in patients with endometrial carcinoma Obstet Gynecol 84 1994 12 16 (Pubitemid 24202948)
12. J.M. Duk, J.G. Aalders, G.J. Fleuren, and H.W. de Bruijn CA 125: a useful marker in endometrial carcinoma Am J Obstet Gynecol 155 1986 1097 1102 (Pubitemid 17176689)
13. J.M. Duk, J.G. Aalders, and G.J. Fleuren Tumor markers CA 125, squamous cell carcinoma antigen, and carcinoembryonic antigen in patients with adenocarcinoma of the uterine cervix Obstet Gynecol 73 1989 661 668 (Pubitemid 19086983)
14. S.S. Gambhir Molecular imaging of cancer with positron emission tomography Nat Rev Cancer 2 2002 683 693 (Pubitemid 37328919)
15. H. Vesselle, R.A. Schmidt, and J.M. Pugsley Lung cancer proliferation correlates with [F-18]fluorodeoxyglucose uptake by positron emission tomography Clin Cancer Res 6 2000 3837 3844
16. A. Buck, H. Schirrmeister, and T. Kühn FDG uptake in breast cancer: correlation with biological and clinical prognostic parameters Eur J Nucl Med Mol Imaging 29 2002 1317 1323 (Pubitemid 44392212)
17. T. Kurokawa, Y. Yoshida, and K. Kawahara Expression of GLUT-1 glucose transfer, cellular proliferation activity and grade of tumor correlate with [F-18]-fluorodeoxyglucose uptake by positron emission tomography in epithelial tumors of the ovary Int J Cancer 109 2004 926 932 (Pubitemid 38500750)
18. K. Nakamura, J. Kodama, and Y. Okumura The SUVmax of 18F-FDG PET correlates with histological grade in endometrial cancer Int J Gynecol Cancer 20 2010 110 115
19. Y. Nakamoto, T. Saga, and T. Ishimori Clinical value of positron emission tomography with FDG for recurrent ovarian cancer AJR Am J Roentgenol 176 2001 1449 1454 (Pubitemid 32510262)
20. P.G. Rose, P. Faulhaber, F. Miraldi, and F.W. Abdul-Karim Positive emission tomography for evaluating a complete clinical response in patients with ovarian or peritoneal carcinoma: correlation with second-look laparotomy Gynecol Oncol 82 2001 17 21 (Pubitemid 32634948)
21. A.C. Paulino, and P.A. Johnstone FDG-PET in radiotherapy treatment planning: Pandora's box ? Int J Radiat Oncol Biol Phys 59 2004 4 5 (Pubitemid 38501500)
22. M.B. Fukui, T.M. Blodgett, and C.H. Snyderman Combined PET-CT in the head and neck: part 2. Diagnostic uses and pitfalls of oncologic imaging Radiographics 25 2005 913 930 (Pubitemid 41196929)
23. M. Hickeson, M. Yun, and A. Matthies Use of a corrected standardized uptake value based on the lesion size on CT permits accurate characterization of lung nodules on FDG-PET Eur J Nucl Med Mol Imaging 29 2002 1639 1647
24. H.H. Chung, J.W. Kim, and K.W. Kang Post-treatment [1F]FDG maximum standardized uptake value as a prognostic marker of recurrence in endometrial carcinoma Eur J Nucl Med Mol Imaging 38 2011 74 80
25. N. Takeshima, Y. Shimizu, and S. Umezawa Combined assay of serum levels of CA125 and CA19-9 in endometrial carcinoma Gynecol Oncol 54 1994 321 326 (Pubitemid 24301907)
26. A.K. Sood, R.E. Buller, and R.A. Burger Value of preoperative CA 125 level in the management of uterine cancer and prediction of clinical outcome Obstet Gynecol 90 1997 441 447 (Pubitemid 27357939)
27. J.T. Soper, A. Berchuck, and G.J. Olt Preoperative evaluation of serum CA 125, TAG 72, and CA 15-3 in patients with endometrial carcinoma Am J Obstet Gynecol 163 1990 1204 1209 (Pubitemid 20377403)